To confirm that the findings of DLL4 down-regulation in cancer cell lines was not just a genetic phenomenon restricted only to the cell lines, we analyzed the DLL4 protein level in normal and cancer patients’ tumor tissues by immunohistochemistry (IHC). This evidence concerns the gene DLL4 and neoplasm.